Download Citation
Article Source:
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Richardson TG,
Leyden GM,
Wang Q,
Bell JA,
Elsworth B,
et al.
(2022)
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
PLOS Biology 20(2): e3001547.
https://doi.org/10.1371/journal.pbio.3001547